| TENX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TENX shares outstanding history going back to 2/26/2018:
Also see: TENX Market Cap History TENX YTD Return |
As of 11/7/2022 Tenax Therapeutics has 27935 TENX shares outstanding. Investors often track the TENX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows TENX share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 2/26/2018.

| TENX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TENX shares outstanding history going back to 2/26/2018:
Also see: TENX Market Cap History TENX YTD Return |
| TENX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
TENX Historical Shares Outstanding: +108.63% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| TENX Stock Price Chart |
| About Tenax Therapeutics Inc |
| Tenax Therapeutics, Inc. is a Phase 3 development-stage pharmaceutical company. Co. is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. Co.'s products include TNX-201 (oral enteric coated imatinib) and TNX-103 (oral levosimendan). Co. is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). Co.'s other programs include TNX-101 (IV), TNX-102 (subcutaneous) and TNX-103 (oral) levosimendan. We show 21 historical shares outstanding datapoints in our coverage of TENX's shares outstanding history. Understanding the changing numbers of TENX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TENX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TENX by allowing them to research TENX shares outstanding history as well as any other stock in our coverage universe. |
| TENX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| TENX Share Performance |
| Shares Outstanding Peers |
| Tenax Therapeutics (TENX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TERN Shares Outstanding History TEVA Shares Outstanding History TFFP Shares Outstanding History TFX Shares Outstanding History TGTX Shares Outstanding History THAR Shares Outstanding History THC Shares Outstanding History THMO Shares Outstanding History THOR Shares Outstanding History THRD Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.